Renowned veterinarians talk catastrophic injury prevention, uniform medication policies, and more in a Translational Medicine Institute video.
The role of a behavior-related gene might explain why some Thoroughbreds start race careers while others don’t, researchers say.
Proposals for research on how bisphosphonates impact racehorses and young racing prospects intended for sale at public auction must be submitted by Oct. 1.
A five-member team of independent CHRB veterinarians and stewards will provide additional review of horses’ medical, training, and racing history and will have authority to scratch horses that do not appear fit to run.
War of Will, who finished eighth in the Kentucky Derby, rebounded with a victory in the 2019 Preakness Stakes.
In a sport where races are won and lost by fractions of a second, subtle problems can have a significant impact on performance. Here’s what veterinarians look for when racehorses aren’t performing at their best.
For the first time in Kentucky Derby history, a winner was demoted for an infraction committed during the running of the race. Stewards disqualified front-runner Maximum Security for causing interference and awarded 65-1 longshot Country House victory.
Track ponies, or pony horses, play important roles both on training and race days.
A variety of initiatives on racing surfaces, race-day scrutiny, and more are in place at all three NYRA tracks—Aqueduct Racetrack, Belmont Park, and Saratoga Race Course.
Drs. Mick Peterson and Wayne McIlwraith weigh in on what we’ve learned about racing surface safety, issues currently at hand, and what the future could bring.
Initiatives include building an equine medical center and quarantine facility on the Louisville, Kentucky, racetrack’s backside, hiring an equine medical director, and more.
Beginning Jan. 1, 2020, 2-year-olds would be prohibited from receiving furosemide within 24 hours of a race at coalition tracks. Beginning in 2021, the same prohibition would extend to all horses participating in any stakes race.
Corrine Sweeney, DVM, is one of the authors of the American College of Veterinary Internal Medicine’s 2014 consensus statement on exercise-induced pulmonary hemorrhage in horses.
Recommendations include avoiding using bisphosphonates in manners inconsistent with indications of use on the label and discontinuing bisphosphonates use in any horses in training regardless of age, having every jurisdiction employ a full-time equine medical director, and more.
Bisphosphonates are FDA-approved for controlling clinical signs associated with navicular syndrome in horses ages 4 and older. Some veterinarians use them off-label to treat other equine bone issues. But could this off-label use be detrimental? One equine veterinarian recently gave a rundown on what research says.
Complete veterinary-record transparency, strict limitations on pain-relieving and/or anti-inflammatory medication/treatment, and banning therapeutic medications or treatments without a qualified veterinary diagnosis from a state-licensed veterinarian are among the agreed-upon initiatives.
Stay on top of the most recent Horse Health news with
